ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 445,69
2,24%
Dow Jones
42 706,56
-0,06%
DAX
20 216,19
1,54%
Brent Oil
75,875
-0,32%
Bitcoin
101 906,98
-0,37%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Nymox Pharmaceutical Corp (NYMX) Cours

Nymox Pharmaceutical Corp

Nymox Pharmaceutical Corp (NYMX)

NASDAQ
0,20
0,00
(0,00%)
Fermé 07 Janvier 10:00PM
Retardé de 15 minutes
0,00
0,00
(0,00%)
Après les heures de négociation: -
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,20
Prix Achat
0,2003
Prix Vente
0,2169
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
18,708M
Clôture Veille
0,20
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
93 540 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,12
Bénéfice par action (BPA)
-0,09
Chiffre d'affairess
-
Bénéfice net
-8,84M

À propos de Nymox Pharmaceutical Corp

Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer.

Secteur
Chemicals & Chem Preps, Nec
Industrie
Chemicals & Chem Preps, Nec
Site Web
www.nymox.com
Siège social
Nassau, Bhs
Fondé
-

NYMX Dernières nouvelles

Plus de nouvelles

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

29 Août 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

13 Mai 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

28 Mars 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

09 Novembre 2023
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

06 Novembre 2023
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

26 Octobre 2023
Edgar (US Regulatory)

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

08 Septembre 2023
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

29 Août 2023
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

02 Août 2023
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

31 Juillet 2023
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

NYMX - Frequently Asked Questions (FAQ)

What is the current Nymox Pharmaceutical share price?
The current share price of Nymox Pharmaceutical is US$ 0,20
How many Nymox Pharmaceutical shares are in issue?
Nymox Pharmaceutical has 93 540 000 shares in issue
What is the market cap of Nymox Pharmaceutical?
The market capitalisation of Nymox Pharmaceutical is USD 18,71M
What is the 1 year trading range for Nymox Pharmaceutical share price?
Nymox Pharmaceutical has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Nymox Pharmaceutical?
The price to earnings ratio of Nymox Pharmaceutical is -2,12
What is the reporting currency for Nymox Pharmaceutical?
Nymox Pharmaceutical reports financial results in USD
What is the latest annual profit for Nymox Pharmaceutical?
The latest annual profit of Nymox Pharmaceutical is USD -8,84M
What is the registered address of Nymox Pharmaceutical?
The registered address for Nymox Pharmaceutical is BAY & DEVEAUX STS., 2ND FLOOR, NASSAU, H4M 2V2
What is the Nymox Pharmaceutical website address?
The website address for Nymox Pharmaceutical is www.nymox.com
Which industry sector does Nymox Pharmaceutical operate in?
Nymox Pharmaceutical operates in the CHEMICALS & CHEM PREPS, NEC sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BOXLBoxlight Corporation
US$ 1,645
(257,61%)
240,3M
SPRCSciSparc Ltd
US$ 1,06
(100,80%)
189,11M
XTIAXTI Aerospace Inc
US$ 0,08261
(99,54%)
1,55B
DHAIDIH Holdings US Inc
US$ 2,8602
(82,18%)
4,62M
NXPLNextPlat Corporation
US$ 1,73
(61,68%)
12,6M
RGFReal Good Food Company Inc
US$ 1,31
(-63,49%)
1,47M
LUNALuna Innovations Incorporated
US$ 0,8744
(-57,35%)
12,29M
GCTKGlucoTrack Inc
US$ 0,1594
(-45,65%)
35,68M
ACONAclarion Inc
US$ 0,1699
(-43,06%)
35,02M
BLRXBioLineRx Ltd
US$ 0,1621
(-40,80%)
44,6M
XTIAXTI Aerospace Inc
US$ 0,08261
(99,54%)
1,55B
NVDANVIDIA Corporation
US$ 149,43
(3,43%)
264,21M
CNSPCNS Pharmaceuticals Inc
US$ 0,11987
(-2,54%)
246,57M
BOXLBoxlight Corporation
US$ 1,645
(257,61%)
240,3M
SPRCSciSparc Ltd
US$ 1,06
(100,80%)
190,36M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
NYMX
Nymox Pharmaceutical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés